Knee Replacement Surgery

2

Review clinical trials related to Knee Replacement Surgery. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty

The goal of this study is to better understand how daily treatment with cannabidiol (CBD) affects the need for opioid pain medication, as well as pain, inflammation and other related symptoms, after knee replacement surgery. The information collected in this study is necessary to help understand whether CBD may be a useful medication before and/or after surgery. The study hypothesis is that CBD exerts opioid-sparing effects through anti-inflammatory, analgesic, and anxiolytic mechanisms.

Participants needed: 380
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Chad BrummettUpdated: Apr 15, 2026Locations: 2
Eligibility criteria

Willing and able to read, understand, and sign the informed consent (English) [+7]

Revision or bilateral total knee arthroplasty [+27]

Status: Not yet recruiting

Effect of Virtual Reality on Patient Outcomes and Satisfaction in Total Knee Replacement

This study aims to evaluate the effectiveness of virtual reality (VR) in managing preoperative anxiety and postoperative pain in patients undergoing total knee replacement. Investigators will assess the impact of preoperative VR training on anxiety levels, explore the effectiveness of relaxing and distracting VR videos for pain management after surgery, and determine the optimal timing for VR application by comparing different VR intervention times. Our goal is to identify how VR can improve both the emotional and physical recovery process for patients undergoing knee replacement surgery.

Participants needed: 64
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Aykut TurgutUpdated: Sep 26, 2025Locations: 1
Eligibility criteria

Patients with an ASA score of 1, 2, or 3 [+2]

Using >30 mg of oral oxycodone or equivalent daily [+10]